Effect of intratympanic dexamethasone, memantine and piracetam on cellular apoptosis due to cisplatin ototoxicity

Journal of Laryngology and Otology

Volumn 126, Issue 11, 2012, Pages 1091-1096

  Topdag, M ^a   Iseri, M ^a   Gelenli, E ^a   Yardimoglu, M ^a   Yazir, Y ^a   Ulubil, S A ^b   Topdag, D O ^a   Ustundag, E ^a  

^a KOCAELI UNIVERSITY   (Turkey)

^b Acibadem Fulya Hospital   (Turkey)

Author keywords

Dexamethasone; Ear, Inner; Memantine; Ototoxicity; Piracetam; Rat

Indexed keywords

CISPLATIN; DEXAMETHASONE; MEMANTINE; PIRACETAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EVOKED BRAIN STEM RESPONSE; FEMALE; HISTOPATHOLOGY; KRUSKAL WALLIS TEST; NONHUMAN; OTOTOXICITY; RANK SUM TEST; RAT; THERAPY EFFECT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; DEXAMETHASONE; FEMALE; LABYRINTH DISEASES; MEMANTINE; PIRACETAM; RATS; RATS, WISTAR; TYMPANIC MEMBRANE;

EID: 84867801825     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215112001855     Document Type: Article

References (31)

1. Frankfurt OS, Robb JA, Sugarbaker EV, Villa L. Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis. Exp Cell Res 1996;226:387-97 (Pubitemid 26260564)
2. Manesse M, Delverdier M, Abella-Bourges N, Sautet J, Cabanié P, Schelcher F. An immunohistochemical study of bovine palatine and pharyngeal tonsils at 21, 60 and 300 days of age. Anat Histol Embryol 1998;27:179-85 (Pubitemid 128353474)
3. Gundersen HJ, Jensen EB. The efficiency of systematic sampling in stereology and its prediction. J Microsc 1987;147: 229-63
4. Peters RC, Mommersteeg PMC, Heijmen PS. The electroreceptor organ of the catfish, Ictalurus melas, as a model for cisplatin induced ototoxicity. Neuroscience 1999;91:745-51 (Pubitemid 29193282)
5. Ravi R, Somani SM, Rybak LP. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol 1995;76:386-94
6. Dehne N, Lautermann J, Petrat F. Cisplatin ototoxicity. Involvement of iron and enhanced formation of superoxide anion radicals. Toxicol Appl Pharmacol 2001;174:27-34 (Pubitemid 32635003)
7. Rybak LP, Whitworth C, Somani S. Application of antioxidants and other agents to prevent cisplatin ototoxicity. Laryngoscope 1999;109:1740-4 (Pubitemid 29533912)
8. Muldoon LL, Pagel MA, Kroll RA. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity. Clin Cancer Res 2000;6:309-15 (Pubitemid 30065007)
9. Campbell KCM, Meech RP, Rybak LP, Hughes LF. D-Methionine protects against cisplatin damage to the stria vascularis. Hear Res 1999;138:13-28
10. Feghali JG, Liu W, Van De Water TR. L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope 2001;111:1147-55 (Pubitemid 32625400)
11. Rybak LP, Husain K, Morris C. Effect of protective agents against cisplatin ototoxicity. Am J Otol 2000;21:513-20 (Pubitemid 30432460)
12. Nadel DM. The use of systemic steroids in otolaryngology. Ear Nose Throat J 1996;75:502-6
13. Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th edn. New York: McGraw-Hill, 1996;1459-85
14. Alexiou C, Arnold W, Fauser C, Schratzenstaller B, Gloddek B, Fuhrmann S. Sudden sensorineural hearing loss: does application of glucocorticoids make sense? Arch Otolaryngol Head Neck Surg 2001;127:253-8 (Pubitemid 32205380)
15. Chen C-Y, Halpin C, Rauch SD. Oral steroid treatment of sudden sensorineural hearing loss: a ten year retrospective analysis. Otol Neurotol 2003;24:728-33 (Pubitemid 37122536)
16. Eisenman DJ, Arts A. Effectiveness of treatment for sudden sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2000;126:1161-6
17. Sha WC, Liou H, Tuomanen EI, Baltimore D. Targeted disruption of the p50 subunit of NF-κβ leads to multifocal defects in immune responses. Cell 1995;80:321-30
18. Baeuerle PA, Baltimore D. NF-κβ: ten years after. Cell 1996;87: 13-20
19. Ma W, Gee K, Lim W. Dexamethasone inhibits IL-12p40 production in lipopolysaccharide-stimulated human monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation protein-1, and NF-κβ transcription factors. J Immunol 2004;172:318-30 (Pubitemid 38020486)
20. Almawi WY, Melemedjian OD. Negative regulation of nuclear factor-κβ activation and function by glucocorticoids. J Mol Endocrinol 2002;28:69-78 (Pubitemid 34428757)
21. Trune DR, Kempton JB. Aldosterone and prednisolone control of auditory dysfunction in MRL/MpJ-Faslpr autoimmune mice. Hear Res 2001;155:9-20 (Pubitemid 32401587)
22. Himeno C, Komeda M, Izumikawa M. Intra-cochlear administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig. Hear Res 2002;167:61-70 (Pubitemid 34756851)
23. Tabuchi K, Oikawa K, Uemaetomari I, Tsuji S,Wada T, Hara A. Glucocorticoids and dehydroepiandrosterone sulfate ameliorate ischemia-induced injury of the cochlea. Hear Res 2003;180: 51-60
24. Sekiya T, Shimamura N, Suzuki S, Hatayama T. Methylprednisolone ameliorates cochlear nerve degeneration following mechanical injury. Hear Res 2001;151:125-32
25. Lamm K, Arnold W. The effect of prednisolone and non-steroidal antiinflammatory agents on the normal and noisedamaged guinea pig inner ear. Hear Res 1998;115:149-61 (Pubitemid 28062832)
26. Takemura K, Komeda M, Yagi M. Direct inner ear infusion of dexamethasone attenuates noise-induced trauma in guinea pig. Hear Res 2004;196:58-68 (Pubitemid 39298896)
27. Oestreicher E, Arnold W, Ehrenberger K, Felix D. Memantine suppresses the glutamatergic neurotransmission of mammalian inner hair cells. ORL J Otorhinolaryngol Relat Spec 1998;60: 18-21 (Pubitemid 28072553)
28. Oliver D, Ludwig J, Reisinger E, Zoellner W, Ruppersberg JP, Fakler B. Memantine inhibits efferent cholinergic transmission in the cochlea by blocking nicotinic acetylcholine receptors of outer hair cells. Mol Pharmacol 2001;60:183-9 (Pubitemid 32595246)
29. Gabryel B, Adamek M, Pudelko A, Malecki A, Trzeciak HI. Piracetam and vinpocetine exert cytoprotective activity and prevent apoptosis of astrocytes in vitro in hypoxia and reoxygenation. Neurotoxicology 2002;23:19-31 (Pubitemid 36559695)
30. Altas E, Ertekin VM, Kuduban O, Gündogdu C, Demirci E, Sütbeyaz Y. Effects of piracetam supplementation on cochlear damage occuring in guinea pigs exposed to irradiation. Biol Pharm Bull 2006;29:1460-5
31. Altas E, Ucuncu H, Aktan B, Selimoglu E. The effect of piracetam in preventing combined cisplatin and gentamicin induced ototoxicity in a guinea pig model. Pain Clinic 2004;16:427-35